6827.TWO
Price:
$10.05
Market Cap:
$650.45M
MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. The company was founded in 2014 and is based in Zhubei, Taiwan.[Read more]
Industry
Biotechnology
IPO Date
2021-10-19
Stock Exchange
TWO
Ticker
6827.TWO
According to MegaPro Biomedical Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -3.75. This represents a change of -9.85% compared to the average of -4.16 of the last 4 quarters.
The mean historical PE Ratio of MegaPro Biomedical Co., Ltd over the last ten years is -8.22. The current -3.75 PE Ratio has changed 4.46% with respect to the historical average. Over the past ten years (40 quarters), 6827.TWO's PE Ratio was at its highest in in the December 2024 quarter at 0. The PE Ratio was at its lowest in in the June 2023 quarter at -6.91.
Average
-8.22
Median
-9.54
Minimum
-18.07
Maximum
0
Discovering the peaks and valleys of MegaPro Biomedical Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.40%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -18.07
Year | PE Ratio | Change |
---|---|---|
2024 | 0 | -100.00% |
2023 | -9.76 | 4.63% |
2022 | -9.33 | -48.38% |
2021 | -18.07 | 48.40% |
2020 | -12.18 | -Infinity% |
The current PE Ratio of MegaPro Biomedical Co., Ltd (6827.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.36
5-year avg
-9.87
10-year avg
-8.22
MegaPro Biomedical Co., Ltd’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MegaPro Biomedical Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MegaPro Biomedical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MegaPro Biomedical Co., Ltd's PE Ratio?
How is the PE Ratio calculated for MegaPro Biomedical Co., Ltd (6827.TWO)?
What is the highest PE Ratio for MegaPro Biomedical Co., Ltd (6827.TWO)?
What is the 3-year average PE Ratio for MegaPro Biomedical Co., Ltd (6827.TWO)?
What is the 5-year average PE Ratio for MegaPro Biomedical Co., Ltd (6827.TWO)?
How does the current PE Ratio for MegaPro Biomedical Co., Ltd (6827.TWO) compare to its historical average?